|
1
|
Solimini R, Ruokolainen O, Cselko Z, Koprivnikar H, Spizzichino L, Papachristou S, González-Marrón A, Nunes E, Carnicer-Pont D, Fernandez E, López AM, Demosthenous E, Kilibarda B, Gallus S, Gómez-Chacón C, Keć I, Valentic M, Ollila H. Good Practice Statements for the treatment of nicotine dependence. Tob Prev Cessat 2023; 9:24. [PMID: 37448706 PMCID: PMC10336859 DOI: 10.18332/tpc/167964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 06/05/2023] [Accepted: 06/10/2023] [Indexed: 07/15/2023]
Affiliation(s)
- Renata Solimini
- Istituto Superiore di Sanita, National Centre on Addiction and Doping, Rome, Italy
| | | | - Zsuzsa Cselko
- National Koranyi Institute of Pulmonology, Budapest, Hungary
| | | | | | | | - Adrián González-Marrón
- Group of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Valles, Spain
| | - Emilia Nunes
- National Programme for Smoking Prevention and Tobacco Control, General-Directorate of Health, Portugal
| | - Dolors Carnicer-Pont
- Tobacco Control Unit and WHO Collaborating Center for Tobacco Control, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain
- Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain
- Consortium for Biomedical Research in Respiratory Diseases (CIBERES), Madrid, Spain
| | - Esteve Fernandez
- Tobacco Control Unit and WHO Collaborating Center for Tobacco Control, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain
- Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain
- Consortium for Biomedical Research in Respiratory Diseases (CIBERES), Madrid, Spain
- School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
| | - Anna Mar López
- Tobacco Control Unit and WHO Collaborating Center for Tobacco Control, Catalan Institute of Oncology (ICO), L’Hospitalet de Llobregat, Spain
- Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain
| | - Elena Demosthenous
- Policy Department of the Cyprus National Addictions Authority, Nicosia, Cyprus
| | - Biljana Kilibarda
- Institute of Public Health of Serbia "Dr Milan Jovanović Batut", Belgrade, Serbia
| | - Silvano Gallus
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
| | | | - Ivona Keć
- Croatian Institute of Public Health, Zagreb, Croatia
| | - Maja Valentic
- Croatian Institute of Public Health, Zagreb, Croatia
| | - Hanna Ollila
- Finnish Institute for Health and Welfare, Helsinki, Finland
| |
Collapse
|
|
2
|
Laguna-Goya N, Antonia Serrano M, Gómez-Chacón C. Revisión de la legislación sobre la investigación clínica en el Sistema Nacional Salud y los servicios de farmacia hospitalaria. Farmacia Hospitalaria 2009; 33:281-4. [DOI: 10.1016/s1130-6343(09)72467-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|